


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.10%
-4.04%
+8.05%
+4.36%
-3.03%
IMNM
Immunome
$20.45
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
IMNM Price Performance
$19.49 (+4.93%)
$14.1 (+45.04%)
$10.25 (+99.51%)
$9.69 (+111.04%)
IMNM has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

IMNM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
IMNM Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IMNM Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels
What is IMNM current stock price?
What are IMNM stock strengths?
What is IMNM Risk Level?
What is IMNM market cap and volume?
What is IMNM current Stock IQ?
Should I buy IMNM stock right now?
Is IMNM a Strong Buy right now?
What does a 'Strong Buy' rating mean for IMNM?
What does a 'Strong Sell' rating mean for IMNM?
What factors influence IMNM's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+1.10%
-4.04%
+8.05%
+4.36%
-3.03%
IMNM
Immunome
Current Price
$20.45
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

IMNM Price Performance
$19.49 (+4.93%)
$14.1 (+45.04%)
$10.25 (+99.51%)
$9.69 (+111.04%)
IMNM Analysts Opinion
IMNM Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
IMNM Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IMNM Street Sentiment is bullish and have negative views on the near-term outlook
IMNM has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
IMNM Stock IQ
IMNM Latest Analysis
Siegall buys Immunome (IMNM) shares worth $149k.
Mon Dec 22, 2025
Friday 12/19 Insider Buying Report: IMNM S. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.On Thursday Immunomes CEO Clay B. Siegall made a $999986 purchase of IMNM buy
Fri Dec 19, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IMNM Stock trends
IMNM Stock performance
IMNM Stock analysis
IMNM investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.